Riccur Pharma Private Limited
About Riccur Pharma Private Limited
Data last updated:
Riccur Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2011PTC223699. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Sundarpalsing Dharamveer Arneja and Kishore Bhooraram Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2019, the company reported a revenue of ₹13.3 Cr, a decline of 59% compared to the previous year. For the same year it recorded a net profit of ₹2.37 Lakh (net margin 0.2%) and EBITDA of ₹3.4 Lakh (EBITDA margin 0.3%).
As per MCA filings, the company has open charges of ₹3.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Riccur Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No 35 Vasant Indl Estate Chs Ltd Saki Vihar Road Kurla West Opp Sakinaka Post Office, Andheri, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Riccur Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riccur Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Riccur Pharma Private Limited, buy the company report.
Financials of Riccur Pharma Private Limited
FY 2019 filings availableRiccur Pharma Private Limited reported revenue of ₹13.3 Cr (down 59% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 59% in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹13.3 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riccur Pharma Private Limited, buy the company report.
Board of directors of Riccur Pharma Private Limited
Riccur Pharma has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sundarpalsing Dharamveer Arneja Also directs: Ringme Gadgets Private Limited | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Kishore Bhooraram Choudhary | Director | 17 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Riccur Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaveri Medi House Private Limited | ₹13.33 Cr (FY 2024) | -3.0% | Davanagere, Karnataka, India | |||
| San Medica Private Limited | ₹13.32 Cr (FY 2025) | 41.0% | New Delhi, Delhi, India | |||
| Feron Healthcare Private Limited | ₹13.31 Cr (FY 2025) | 28.0% | Secunderabad, Telangana, India | |||
| Riccur Pharma Private Limitedthis company | ₹13.3 Cr (FY 2019) | ₹2.37 Lakh | 0.2% | -59.0% | Mumbai, Maharashtra, India | |
| Quality Lifesciences Private Limited | ₹13.24 Cr (FY 2025) | -5.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Riccur Pharma Private Limited, buy the company report.
Auditor
Riccur Pharma Private Limited is audited by RISHI SEKHRI AND ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI SEKHRI AND ASSOCIATES | FY 2019 | 128216W |
Shareholding
The shareholding of Riccur Pharma Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Riccur Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2019 | 100281146 | Others | ₹3.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Riccur Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riccur Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Riccur Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Riccur Pharma Private Limited, buy the company report.
Recent activity
Riccur Pharma Private Limited has 13 board changes on record since 2013: 2 appointments and 11 cessations. The latest: Kishore Bhooraram Choudhary was appointed as Director on 17 Mar 2020.
5 earlier events are in the company report.
Frequently asked questions
Riccur Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 November 2011 (15+ years old) and is registered under CIN U24230MH2011PTC223699.
Riccur Pharma has 2 current directors:
- Sundarpalsing Dharamveer Arneja - Director
- Kishore Bhooraram Choudhary - Director
The latest financial statements of Riccur Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Riccur Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Riccur Pharma is U24230MH2011PTC223699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riccur Pharma was incorporated on 08 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Riccur Pharma by revenue are Kaveri Medi House Private Limited, San Medica Private Limited, Feron Healthcare Private Limited, Quality Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kishore Bhooraram Choudhary was appointed as Director on 17 Mar 2020. Vipul Himmatlal Patel ceased to be Director on 17 Mar 2020. Gurmeetsingh Raghuveersingh Chhabra ceased to be Director on 08 Nov 2019. Riccur Pharma has 13 board changes on record in total.
The registered office of Riccur Pharma is at Unit No 35 Vasant Indl Estate Chs Ltd Saki Vihar Road Kurla West Opp Sakinaka Post Office, Andheri, Mumbai, Maharashtra, India – 400072.
Riccur Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Riccur Pharma has open charges of ₹3.5 Cr and no satisfied charges on record as per latest MCA filings.